PolyU secures HK$62.6M grant for development of decentralised collaborative GenAI with healthcare and hospital applications.
Key Details
- 1The Hong Kong Polytechnic University (PolyU) was awarded HK$62.6 million for its 'Collaborative Generative AI (Co-GenAI)' project.
- 2Project funding includes HK$41.79 million from the Research Grants Council and additional contributions from PolyU and partner universities.
- 3Co-GenAI aims to decentralise AI model training, enabling hundreds of domain-specific models to be fused into a robust, cost-effective AI foundation model.
- 4Collaborators include technology companies and major hospitals, such as Huashan Hospital (Fudan University), Shandong Cancer Hospital, and Sun Yat-sen University Cancer Center.
- 5The initiative targets real-world applications in healthcare and technology to democratise GenAI access and reduce reliance on centralised GPUs.
Why It Matters
The project could significantly lower the barriers for hospitals and research groups to develop and deploy specialised AI solutions, increasing innovation and participation in imaging AI. Decentralised GenAI technologies may offer more sustainable, equitable ways for healthcare organisations to access advanced AI capabilities.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.